Bibliographic Details
| Title: |
Black Seed Oil-Based Curcumin Nanoformulations Ameliorated Cuprizone-Induced Demyelination in the Mouse Hippocampus. |
| Authors: |
Alam, Mohammad Zubair, Bagabir, Hala Abubaker, Zaher, Mohammad Alameen Faisal, Alqurashi, Thamer M. A., Alghamdi, Badrah S., Kazi, Mohsin, Ashraf, Ghulam Md, Alshahrany, Gadah Ali, Alzahrani, Noor Ahmed, Bakhalgi, Rafal Mohammed, Juweiriya, Al-Thepyani, Mona, AboTaleb, Hanin Abdulbaset, Aldhahri, Rahaf Saeed, El-Aziz, Gamal Said Abd, Al-Abbasi, Fahad A., Eibani, Loay Khaled, Alzahrani, Faisal Jaman, Khan, Mohd Sajjad Ahmad |
| Source: |
Molecular Neurobiology; Jan2025, Vol. 62 Issue 1, p604-625, 22p |
| Abstract: |
Multiple sclerosis (MS) is a neurodegenerative disease characterized by the demyelination of nerves, axonal damage, and neuroinflammation. Cognition impairment, pain, and loss of mobility are some of the usual complications of MS. It has been postulated that the overproduction of proinflammatory cytokines and reactive oxygen species (ROS) are the main factors that contribute to MS pathology. Among various animal models, the cuprizone model is the most widely used model for investigating MS-related pathology. We assessed the effects of cuprizone along with the protective effects of some black seed oil-based nanoformulations of curcumin with and without piperine, in mice hippocampus in terms of the changes in antioxidant enzymes, transcription factors, and cytokines during demyelination and remyelination processes. The results of behavioral studies point toward impairment in working memory following the feeding of cuprizone for 5 weeks. However, in treatment groups, mice seemed to prevent the toxic effects of cuprizone. Nanoformulations used in this study were found to be highly effective in lowering the amount of ROS as indicated by the levels of antioxidant enzymes like catalase, superoxide dismutase, glutathione, and glutathione peroxidase. Moreover, nanoformulations CCF and CCPF were observed resisting the toxic effects of cuprizone. We observed greater expression of NFκB-p65 in the CPZ group than in the control group. CCF nanoformulation had a better inhibitory effect on NFκB-p65 than other formulations. Histological examination of the hippocampus was also conducted. Nanoformulations used here were found effective in reversing MS-related pathophysiology and hence have the potential to be applied as adjuvant therapy for MS treatment. [ABSTRACT FROM AUTHOR] |
|
Copyright of Molecular Neurobiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
